Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.

Butterfield, D Allan; Palmieri, Erika M; Castegna, Alessandra

Butterfield, D Allan; Palmieri, Erika M; Castegna, Alessandra.

Affiliation

Butterfield DA; a Department of Chemistry, and Sanders-Brown Center on Aging , University of Kentucky , Lexington , KY , USA.
Palmieri EM; b Department of Biosciences, Biotechnologies and Biopharmaceutics , University of Bari 'Aldo Moro' , Bari , Italy.
Castegna A; b Department of Biosciences, Biotechnologies and Biopharmaceutics , University of Bari 'Aldo Moro' , Bari , Italy.

Expert Rev Proteomics ; 13(3): 259-74, 2016.

Article in En | MEDLINE | ID: mdl-26837425

Subject(s)

Alzheimer Disease/metabolism; Mitochondrial Proteins/metabolism; Parkinson Disease/metabolism; Proteomics/methods; Alzheimer Disease/diagnosis; Animals; Biomarkers/metabolism; Humans; Molecular Diagnostic Techniques/methods; Parkinson Disease/diagnosis

Key words

Alzheimer disease; Parkinson disease; Proteomics; clinical biomarkers; mitochondria; neurodegeneration; redox proteomics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Mitochondrial Proteins / Proteomics / Alzheimer Disease Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google